Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 34 new drug applications...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- July 6, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 34 new drug applications...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Center for Scientific Review; Notice of Closed Meetings
Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information
The Office of the Assistant Secretary for Health (OASH or we) is opening a public docket to solicit...
Patient Safety Organizations: Voluntary Relinquishment for the Cassatt Patient Safety Organization
The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule) authorizes AHRQ, on beha...